HeraMED Limited (FRA:1I4)

Market Cap	18.26M
Revenue (ttm)	180.28K
Net Income (ttm)	-2.53M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,000
Average Volume	106,241
Open	0.0170
Previous Close	0.0175
Day's Range	0.0170 - 0.0175
52-Week Range	0.0035 - 0.0535
Beta	n/a
RSI	46.05
Earnings Date	Nov 28, 2025

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant moth...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2011
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1I4

Financial Performance

In 2024, HeraMED's revenue was 364,328, a decrease of -39.90% compared to the previous year's 606,226. Losses were -5.49 million, -18.96% less than in 2023.

Financial numbers in AUD